Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Summary

This study is designed to develop our understanding of the efficacy and safety of using lumiracoxib in the treatment of patients with acute gout. This is a multi-center, double-blind, randomized, parallel group study comparing a single daily dose of 400 mg lumiracoxib with the established dose of indomethacin 50 mg taken three times a day in terms of efficacy

Timeline

Start

2005-06

Primary completion

—

Completion

—

Drugs

Indications